← Back to Search

BinaxNOW Rapid Antigen System for COVID-19

N/A

Waitlist Available

Led By Ryan Coller, MD, MPH

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month

Awards & highlights

Study Summary

This trial is studying how parents of children with medical complexity decide whether to send their child to school in-person or attend from home, and whether in-home COVID testing affects this decision.

Eligible Conditions

COVID-19
Coronavirus
Children With Medical Complexity

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month, 6 month, 9-12 month, 15 month, 18 month, 21 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in COVID test rate at home: Number of total tests completed as compared to number of tests expected

Change in Cues: Has a teacher or staff member encouraged child to attend school in-person? (Y/N)

Inverse PCR

+13 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Caregiver of Children with medical complexity (CMC)Experimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

BinaxNOW Rapid Antigen System

2021

N/A

~80

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,336 Total Patients Enrolled

14 Trials studying COVID-19

1,667,154 Patients Enrolled for COVID-19

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,963 Previous Clinical Trials

2,674,690 Total Patients Enrolled

12 Trials studying COVID-19

63,535 Patients Enrolled for COVID-19

Ryan Coller, MD, MPHPrincipal InvestigatorUniversity of Wisconsin, Madison

3 Previous Clinical Trials

435 Total Patients Enrolled

1 Trials studying COVID-19

71 Patients Enrolled for COVID-19

Media Library

BinaxNOW Rapid Antigen System Clinical Trial Eligibility Overview. Trial Name: NCT04895085 — N/A

COVID-19 Research Study Groups: Caregiver of Children with medical complexity (CMC)

COVID-19 Clinical Trial 2023: BinaxNOW Rapid Antigen System Highlights & Side Effects. Trial Name: NCT04895085 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left in this research endeavor for volunteers?

"This medical trial, which was posted on April 27th 2021 and last revised on August 15th 2022, is not currently accepting patient applications. Despite this fact, 1037 other clinical studies are still actively searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance

2021. "ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04895085.